Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
NAD+ injection benefits are not established by controlled human research. Clinics and telehealth programs describe more energy, sharper thinking and slower aging, but a 2026 systematic review found no eligible outcomes trials of intravenous or intramuscular NAD+ for anti-aging or wellness, and its authors called the clinical effectiveness inconclusive. What exists for NAD injections is mostly small pilots, clinic records and case reports, so the clinical case for NAD therapy by injection is thin.
I’m Judy. I’m not a medical professional, and this page is built from published studies and FDA pages, not from my own results with NAD+. The health claims below come from the sources linked in the text and listed at the end of the page, and where the evidence is small, short or missing I say so in the sentence. For how NAD+ compares with the oral supplement version, see my guide to NAD+ vs NMN.
What Are the Benefits of NAD+ Injections?
The honest answer is that no benefit of NAD+ injections has been shown in a controlled human trial. A 2026 systematic review in Ageing Research Reviews covered 113 studies published from January 2010 to October 2025, 33 of them in humans. Oral NAD+ precursors raised NAD-related markers in blood, but effects on function, metabolism and other healthspan outcomes were mixed and often null. No eligible outcomes trial tested intravenous or intramuscular NAD+ itself for anti-aging or wellness.
A September 2026 narrative review of IV NAD+ in Frontiers in Aging reached a similar place. It describes the human evidence as sparse, made up mostly of small uncontrolled studies, observational work and case reports. It notes limited, self-reported improvements in sleep-related outcomes and neurologic symptoms, but says small samples, no placebo groups and short follow-up leave their meaning uncertain. Its conclusion is that the evidence is preliminary and not enough to support routine wellness use.
Energy and fatigue
Energy is the benefit people ask about most. Shed’s NAD+ page, read on October 19, 2026, says its nasal spray and injections aid the body’s energy production, metabolism and well-being. The reviews above do not report a controlled trial showing that NAD injections raise energy levels in patients or healthy adults, so treat energy as a hope and not a result.
Anti-aging and cellular repair
Rodent studies look more promising. The Ageing Research Reviews paper found NAD+ boosting was frequently linked to better metabolic, mitochondrial and functional outcomes in rodents, with effects that varied across models. Mouse results do not tell you what an injection will do for a woman in her forties or fifties.
Does Subcutaneous NAD+ Work Better Than IV NAD+ Infusion?
Subcutaneous, intramuscular and intravenous administration
There are three common routes of administration for NAD injections and infusions. Subcutaneous (SubQ) injection goes under the skin, intramuscular goes into muscle, and intravenous delivery goes into a vein as an infusion over a session. The research does not show that any one route gives better outcomes.
The reviews I read report no comparison of one route against another for any health goal. The human studies above are about intravenous NAD+, and the systematic review found no intramuscular outcomes trials either. Neither review’s abstract mentions subcutaneous injection, and the Frontiers in Aging review never uses the word, so these sources give no trial evidence for it, good or bad. Both reviews call for larger randomized trials, and the systematic review singles out injected and infused (parenteral) approaches.
What the absorption and bioavailability claims leave out
Clinic and telehealth pages like to talk about absorption and bioavailability, usually with the claim that IV is stronger and subcutaneous is gentler or steadier. The published human data do not settle that. In a pilot of a 6 hour IV NAD+ infusion in eight healthy men aged 30 to 55 (plus three controls), with the infusion running at 3 micromoles a minute, plasma NAD+ and its metabolites did not change for the first 2 hours, and the authors concluded NAD+ was rapidly and completely removed from the plasma during that time. That measures what happens in the blood, not whether cells benefit or whether you feel better.
What Do Human Studies Show About IV NAD+?
The most detailed recent human data I found are about tolerability, not benefit. In a 2026 retrospective review of records from a commercial wellness clinic, six people received 500 mg of NAD+ by IV on four consecutive days, and eight received NR by IV. Those who received NAD+ reported moderate to severe gastrointestinal symptoms, a faster heart rate and chest pressure during the infusions, and the symptoms resolved when the infusion ended. Symptoms stretched infusions to an average of 97 minutes, compared with 37 minutes for a group given nicotinamide riboside (NR) by IV. ALT, AST, hsCRP, kidney markers and TSH did not change significantly. Alkaline phosphatase, a liver enzyme, fell significantly in the NAD+ group but stayed in the normal range. HDL cholesterol fell in the NAD+ group and HbA1c fell in the NR group, and the authors called these exploratory and variable. Most of the authors worked for the clinic, and the study design cannot show cause and effect, so treat it as a tolerability snapshot.
What Are the Benefits of Injecting NAD+ Three Times a Week?
None have been shown for that schedule specifically. Shed’s NAD+ page, which I read on October 19, 2026, lists its injection program as taken 3 times per week. The page also lists support for things like slowed aging, boosted energy levels and reduced cognitive decline. The research above does not establish those results for injections, so read that list as the company’s marketing language and not as a finding.
How Much NAD+ Is in an Injection Dose?
The dose varies by provider, and the reviews found no trial that defined an effective NAD injection dose for anti-aging or wellness. The studies above used very different amounts. The clinic review gave 500 mg by IV on four consecutive days, and the infusion pilot ran 3 micromoles a minute for 6 hours. Shed’s page, read on October 19, 2026, lists its injection program as a one month supply in a 200 mg/ml, 6 ml vial, taken 3 times per week, and its nasal spray as a 120 mg to 180 mg daily dose. A dose from one program or clinic session is not a medical standard, so ask your prescriber how a dose was chosen for you and how it is adjusted.
Are NAD+ Injections FDA Approved?
If a clinic or telehealth program supplies NAD+ injections as a compounded drug, the FDA states plainly that compounded drugs are not FDA-approved and that it does not review them for safety, effectiveness or quality before they reach patients. That page also says drugs compounded under section 503A must be made based on a valid patient-specific prescription.
The FDA’s list of bulk drug substances nominated for compounding under section 503A (updated May 14, 2026) places nicotinamide adenine dinucleotide (NAD) and NADH in Category 1, “Bulk Drug Substances Under Evaluation.” One related form, beta-nicotinamide adenine dinucleotide disodium salt trihydrate, sits in Category 3, “Nominated Without Adequate Support.” If you want the cost side of this, I explain what drives price in my guide to how much NAD+ therapy costs.
What Are the Side Effects and Safety Risks of NAD+ Injections?
The Frontiers in Aging review lists nausea, cramping, flushing and chest discomfort as reported adverse effects of IV NAD+, and says long-term safety data are lacking. Quality is its own question. An FDA reminder to compounders (page current as of 10/30/2024) says the agency knows of compounders using food-grade NAD+ from repackagers to make intravenous products, and that food-grade ingredients carry a high risk of microbes and endotoxins. The same page says FDA received adverse event reports after use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue, some needing medical treatment, consistent with excessive endotoxin levels.
That is a reason to ask any provider where the product is compounded and how it is tested. For the full list of what to ask, see my page on NAD+ side effects.
Do You Need a Prescription for NAD+ Injections?
Yes, buying NAD+ injections without a prescription is not the route the FDA describes. Under the FDA’s section 503A rules above, a compounded drug is made for a specific patient based on a valid patient-specific prescription. Be wary of any seller offering vials with no clinician review, because that skips the one check that matters for an injectable. A prescriber can also tell you whether your medications and health history make an injection unwise.
If You Want to Ask a Clinician About NAD+ Injections
If you decide to explore it, a licensed clinician should decide whether injections are right for you, not a product page. Shed’s NAD+ page, read on October 19, 2026, says you complete an online medical questionnaire, choose a program and check out, and that a licensed provider reviews your information and, if approved, medication is shipped to you. It lists prescription medications among what you get, and offers an NAD+ nasal spray plan and an NAD+ injection plan. See Shed’s NAD+ page here. Approval is the provider’s decision, and the benefits list on that page is marketing language, as covered above.
Talk to Your Clinician First
I’m not a doctor, and this page is not medical advice. Whether an NAD+ injection makes sense for you depends on your health history, your medications and what you hope to get from it. Take the studies linked below to your prescriber and ask how they apply to your medications and goals. NAD+ injections are not a substitute for a weight loss treatment you and your clinician have chosen.
Frequently Asked Questions
What does NAD therapy do when you inject it?
Short-term IV NAD+ or NMN has been linked to transient rises in circulating NAD+ in small studies, but what that does for your health has not been shown. A 2026 systematic review found no eligible outcomes trials of IV or intramuscular NAD+ for anti-aging or wellness.
Are NAD injections safe for patients?
The published safety record is thin. Reported effects of IV NAD+ include nausea, cramping, flushing and chest discomfort, and long-term safety data are lacking. The FDA has also warned about food-grade NAD+ being used to make injectable products. A licensed clinician should weigh the risks for you.
How often are NAD+ injection doses taken?
It depends on the program, and doses and maintenance schedules differ between providers. Shed’s page lists its injection program as taken 3 times per week. No controlled trial has tested a schedule for anti-aging or wellness, so the schedule is set by the provider, not by evidence of benefit.
Are NAD+ injections better than IV drips?
Nobody has shown that. The human research on direct NAD+ is small, mostly uncontrolled and mostly about IV use, and no head-to-head comparison of the two routes appears in the reviews cited here.
Can NAD+ injections help with weight loss?
None of the sources on this page shows a weight loss benefit. They do not report a controlled trial of injected NAD+ for weight loss, so a weight loss claim for NAD+ injections is unsupported by this evidence.
Do you need a prescription for NAD+ injections?
Yes. The FDA says compounded drugs made under section 503A must be based on a valid patient-specific prescription, and a licensed clinician makes that decision.
Sources
- NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence, Ageing Research Reviews, 2026
- Narrative review of intravenous NAD+ and NAD+ precursors in wellness and translational medicine, Frontiers in Aging, 2026
- Intravenous infusion of NAD+ versus nicotinamide riboside: a retrospective tolerability pilot study in a real-world setting, Frontiers in Aging, 2026
- A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD, Frontiers in Aging Neuroscience, 2019
- FDA: human drug compounding laws and policies
- FDA: bulk drug substances nominated for use in compounding under section 503A (updated May 14, 2026)
- FDA: reminds compounders to use ingredients suitable for sterile compounding